Aplasia cutis congenita in surviving co-twin after propylthiouracil exposure in utero

Journal of Pediatric Endocrinology and Metabolism

Volumn 24, Issue 3-4, 2011, Pages 215-218

  Löllgen, Ruth M ^a   Calza, Anne Marie ^a   Schwitzgebel, Valérie M ^a   Pfister, Riccardo E ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

antithyroid drugs; aplasia cutis congenital; methimazole; propylthiouracil; vanishing twin.

Indexed keywords

ANTIINFECTIVE AGENT; LIOTHYRONINE; PROPRANOLOL; PROPYLTHIOURACIL; THYROTROPIN; THYROTROPIN RECEPTOR ANTIBODY; THYROXINE;

ADULT; ARTICLE; CASE REPORT; CONSERVATIVE TREATMENT; FEMALE; FETUS ECHOGRAPHY; FETUS RESORPTION; FREE LIOTHYRONINE INDEX; FREE THYROXINE INDEX; GRAVES DISEASE; HUMAN; NEWBORN; PRENATAL DRUG EXPOSURE; SKIN APLASIA; SURVIVAL; THYROID FUNCTION TEST; TWINS; VANISHING TWIN SYNDROME;

ABNORMALITIES, DRUG-INDUCED; ANTITHYROID AGENTS; DISEASES IN TWINS; ECTODERMAL DYSPLASIA; FEMALE; GESTATIONAL AGE; GRAVES DISEASE; HUMANS; INFANT, NEWBORN; MATERNAL EXPOSURE; PREGNANCY; PREGNANCY COMPLICATIONS; PROPYLTHIOURACIL;

EID: 79955494690     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPEM.2011.099     Document Type: Article

References (26)

1. Frieden I. Aplasia cutis congenita: a clinical review and proposal for classification. J Am Acad Dermatol 1986;14:646-60. (Pubitemid 16167353)
2. Mandel SJ, Brent GA, Larsen PR. Review of antithyroid drug use during pregnancy and report of a case of aplasia cutis. Thyroid 1994;4:129-33. (Pubitemid 24145896)
3. Martinez-Regueira S, Vazquez-Lopez ME, Somoza-Rubio C, Morales-Redondo R, Gonzalez-Gay MA. Aplasia cutis congenita in a defi ned population from northwest Spain. Pediatr Dermatol 2006;23:528-32. (Pubitemid 44800268)
4. Weetman A. Graves'disease. N Engl J Med 2000;343:1236-48.
5. Clark SM, Saade GR, Snodgrass WR, Hankins GD. Pharmacokinetics and pharmacotherapy of thionamides in pregnancy. Ther Drug Monit 2006;28:477-83. (Pubitemid 44181481)
6. Davies TF, Roti E, Braverman LE, DeGroot LJ. Thyroid controversy stimulating antibodies. J Clin Endocrinol Metab 1998;83: 3777-85.
7. Mujtaba Q, Burrow GN. Treatment of hyperthyroidism in pregnancy with propylthiouracil and methimazole. Obstet Gynecol 1975;46:282-6.
8. Di Gianantonio E, Schaefer C, Mastroiacovo PP, Cournot MP, Benedicenti F, et al. Adverse effects of prenatal methimazole exposure. Teratology 2001;64:262-6. (Pubitemid 33032708)
9. Mortimer RH, Cannell GR, Addison RS, Johnson LP, Roberts MS, et al. Methimazole and propylthiouracil equally cross the perfused human term placental lobule. J Clin Endocrinol Metab 1997;82:3099-102. (Pubitemid 27385681)
10. Gardner D, Cruikshank DP, Hays PM, Cooper DS. Pharmacology of propylthiouracil (PTU) in pregnant hyperthyroid women: correlation of maternal PTU concentrations with cord serum thyroid function tests. J Clin Endocrinol Metab 1986;62:217-20. (Pubitemid 16186869)
11. Momotani N, Noh JY, Ishikawa N, Ito K. Effects of propylthiouracil and methimazole on foetal thyroid status in mothers with Graves'hyperthyroidism. J Clin Endocrinol Metab 1997; 82:3633-6. (Pubitemid 27509348)
12. Cooper DS. Antithyroid drugs. N Engl J Med 2005;352:905-17. (Pubitemid 40300299)
13. Wing DA, Millar LK, Koonings PP, Montoro MN, Mestman JH. A comparison of propylthiouracil versus methimazole in the treatment of hyperthyroidism in pregnancy. Am J Obstet Gynecol 1994;170:90-5. (Pubitemid 24084037)
14. Holt WA, Talbert L, Thomas CG Jr, Rankin P. Hyperthyroidism during pregnancy. Obstet Gynecol 1970;36:779-85.
15. Goluboff LG, Sisson JC, Hamburger JI. Hyperthyroidism associated with pregnancy. Obstet Gynecol 1974;44:107-16.
16. Ghaneim A, Atkins P. Management of thyrotoxicosis in pregnancy. Int J Clin Pract 1998;52:36-8. (Pubitemid 28056687)
17. Momotani N, Ito K. Treatment of pregnant patients with Basedow's disease. Exp Clin Endocrinol 1991;97:268-74.
18. Greenman GW, Gabrielson MO, Howard-Flanders J, Wessel MA. Thyroid dysfunction in pregnancy. N Engl J Med 1962;267: 426-31.
19. Herbst AL SH. Hyperthyroidism during pregnancy. N Engl J Med 1965;273:627-33.
20. Cheron RG, Kaplan MM, Larsen PR, Selenkow HA, Crigler JF Jr. Neonatal thyroid function after propylthiouracil therapy for maternal Graves'disease. N Engl J Med 1981;304:525-8. (Pubitemid 11056499)
21. Hollingsworth DR, Austin E. Thyroxine derivatives in amniotic fluids. J Pediatr 1971;79:923-9.
22. Cambiaghi S, Schiera A, Tasin L, Gelmetto C. Aplasia cutis congenita in surviving co-twins: 4 unrelated cases. Pediatr Dermatol 2001;18:511-5. (Pubitemid 34111145)
23. Leauté-Labreze C, Depaire-Duclos F, Sarlangue J, Fontan D, Sandler B, et al. Congenital cutaneous defects as complications in surviving co-twins. Arch Dermatol 1998;134:1121-4.
24. Momotani N, Ito K, Hamada N, Ban Y, Nishikawa Y, et al. Maternal hyperthyroidism and congenital malformations in the offspring. Clin Endocrinol (Oxf) 1984;20:695-700. (Pubitemid 14105342)
25. Mandel SJ, Cooper DS. The use of antithyroid drugs in pregnancy and lactation. J Clin Endocrinol Metab 2001;86:2354-9. (Pubitemid 32545676)
26. Landy HJ, Keith LG. The vanishing twin: a review. Hum Reprod Update 1998;4:177-83. (Pubitemid 28306295)